Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review

The purpose of this pictorial review is to discuss the usefulness and limitations of diffusion-weighted (DW) MR imaging of the liver, demonstrating DW images of a variety of focal hepatic diseases. We include hepatocellular carcinoma, borderline-lesions in cirrhosis, metastasis, cavernous hemangioma, cyst, focal nodular hyperplasia, hepatic adenoma, abscess, and hematoma. DW imaging is an important supplementary sequence of routine MR imaging protocols of the liver. Radiologists need to understand its usefulness and limitations in the detection and characterization of benign and malignant focal hepatic diseases.

[1]  I. Wanless,et al.  Terminology of nodular hepatocellular lesions , 1995 .

[2]  M. Fukunaga,et al.  Hemorrhagic and nonhemorrhagic stroke: diagnosis with diffusion-weighted and T2-weighted echo-planar MR imaging. , 1997, Radiology.

[3]  D. Mitchell,et al.  Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images. , 1998, AJR. American journal of roentgenology.

[4]  M. Han,et al.  Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging. , 1998, AJR. American journal of roentgenology.

[5]  Toshihiro Kumabe,et al.  Malignant astrocytic tumors: clinical importance of apparent diffusion coefficient in prediction of grade and prognosis. , 2006, Radiology.

[6]  M. Kanematsu,et al.  Diffusion‐weighted imaging of the liver: Optimizing b value for the detection and characterization of benign and malignant hepatic lesions , 2008, Journal of magnetic resonance imaging : JMRI.

[7]  M. Kanematsu,et al.  Evaluating local hepatocellular carcinoma recurrence post‐transcatheter arterial chemoembolization: Is diffusion‐weighted MRI reliable as an indicator? , 2008, Journal of magnetic resonance imaging : JMRI.

[8]  Michiie Sakamoto,et al.  Pathologic diagnosis of early hepatocellular carcinoma: A report of the international consensus group for hepatocellular neoplasia , 2009, Hepatology.

[9]  Katsuhiro Nasu,et al.  Diffusion-weighted imaging of surgically resected hepatocellular carcinoma: imaging characteristics and relationship among signal intensity, apparent diffusion coefficient, and histopathologic grade. , 2009, AJR. American journal of roentgenology.

[10]  E. Hecht,et al.  Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI , 2010, European Radiology.

[11]  K. Togashi,et al.  Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases , 2010, European Radiology.

[12]  Can the Patient With Cirrhosis Be Imaged for Hepatocellular Carcinoma Without Gadolinium?: Comparison of Combined T2-Weighted, T2*-Weighted, and Diffusion-Weighted MRI With Gadolinium-Enhanced MRI Using Liver Explantation Standard , 2011, Journal of computer assisted tomography.

[13]  Jae-Joon Chung,et al.  Detection of small intrahepatic metastases of hepatocellular carcinomas using diffusion-weighted imaging: comparison with conventional dynamic MRI. , 2011, Magnetic resonance imaging.

[14]  U. Motosugi,et al.  Imaging study of early hepatocellular carcinoma: usefulness of gadoxetic acid-enhanced MR imaging. , 2011, Radiology.

[15]  M. Ronot,et al.  High-b-value diffusion-weighted MR imaging of benign hepatocellular lesions: quantitative and qualitative analysis. , 2012, Radiology.